Ovintiv director reports 408 deferred share units acquisition
Ovintiv Inc. director reported a routine equity change involving deferred share units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ovintiv Inc. director reported a routine equity change involving deferred share units. On 12/31/2025, the director acquired 408 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. These DSUs were received as dividend equivalents in lieu of cash dividends for the fourth quarter of 2025 and will be held until the director retires from the Board.
Following this transaction, the director beneficially owned 54,019 derivative securities in the form of DSUs, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Share Unit | 408 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each Deferred Share Unit ("DSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and yields dividend equivalent DSUs. DSUs are held until retirement from the Board.
- F2. Dividend equivalent DSUs received in lieu of cash dividends for the fourth quarter of 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Ovintiv (OVV) report in this Form 4?
Why did the Ovintiv (OVV) director receive 408 DSUs?
What is the relationship of the reporting person to Ovintiv (OVV)?
Are the Ovintiv (OVV) DSUs acquired in this Form 4 held directly or indirectly?
AI-generated analysis. How Rhea-AI works. Not financial advice.